Switching on resolution to treat RA moves closer to reality

Nat Rev Rheumatol. 2021 Feb;17(2):73-74. doi: 10.1038/s41584-020-00549-z.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / drug effects
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / drug effects
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism*
  • Arthritis, Rheumatoid / pathology
  • Biological Variation, Population
  • Disease Progression
  • Dual Specificity Phosphatase 1 / drug effects
  • Dual Specificity Phosphatase 1 / metabolism
  • Fibroblasts / metabolism
  • Glucocorticoids / pharmacology
  • Humans
  • Inflammation / metabolism*
  • Inflammation / physiopathology
  • Macrophages / metabolism
  • Mice
  • Models, Animal
  • Receptor, Melanocortin, Type 1 / agonists
  • Receptor, Notch3 / metabolism
  • Receptors, Cell Surface / drug effects
  • Receptors, Cell Surface / metabolism
  • Synoviocytes / metabolism*

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD163 antigen
  • Glucocorticoids
  • NOTCH3 protein, human
  • Receptor, Melanocortin, Type 1
  • Receptor, Notch3
  • Receptors, Cell Surface
  • DUSP1 protein, human
  • Dual Specificity Phosphatase 1